These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21030837)

  • 21. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interleukins as modulators of the immune system].
    Röllinghoff M
    Ric Clin Lab; 1984; 14 Suppl 2():15-20. PubMed ID: 6241743
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulatory T cells in primary immunodeficiency diseases.
    Torgerson TR; Ochs HD
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):515-21. PubMed ID: 17989528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Customized antigens for desensitizing allergic patients.
    Ferreira F; Wallner M; Thalhamer J
    Adv Immunol; 2004; 84():79-129. PubMed ID: 15246251
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.
    Akdis CA; Akdis M
    J Allergy Clin Immunol; 2009 Apr; 123(4):735-46; quiz 747-8. PubMed ID: 19348912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthy immune response to allergens: T regulatory cells and more.
    Akdis M
    Curr Opin Immunol; 2006 Dec; 18(6):738-44. PubMed ID: 17023149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic responses during allergen-specific immunotherapy for respiratory allergy.
    Gurka G; Rocklin R
    Ann Allergy; 1988 Oct; 61(4):239-45. PubMed ID: 2459992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Applications and goals of molecular biology].
    Cerino Javier R; Ortiz Aldana I; Isart Fagundo E; García Caballero R
    Rev Alerg Mex; 1995; 42(2):24-7. PubMed ID: 7627562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nature, function, and regulation of suppressor T-cells in the mouse.
    Argyris BF
    Immunol Ser; 1989; 45():419-36. PubMed ID: 2535103
    [No Abstract]   [Full Text] [Related]  

  • 31. The primary immunodeficiencies (1).
    Rosen FS; Cooper MD; Wedgwood RJ
    N Engl J Med; 1984 Jul; 311(4):235-42. PubMed ID: 6234467
    [No Abstract]   [Full Text] [Related]  

  • 32. Subpopulation of T lymphocytes in primary immunodeficiency diseases.
    Sanal O; Altintaş G; Yeğin O; Ersoy F; Berkel AI
    Turk J Pediatr; 1985; 27(1):3-10. PubMed ID: 3157252
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW F1 hybrid mice.
    Michalski JP; McCombs CC; Roubinian JR; Talal N
    Clin Exp Immunol; 1983 Apr; 52(1):229-33. PubMed ID: 6222853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human suppressor cells.
    Delespesse G
    Acta Rhumatol Belg; 1978; 2(3-4):124-6. PubMed ID: 160181
    [No Abstract]   [Full Text] [Related]  

  • 35. Bibliography. Current world literature. Primary immune deficiency disease.
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):531-4. PubMed ID: 15051974
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacology of acute allergic disorders.
    Foreman JC; Lichtenstein LM
    Annu Rev Med; 1980; 31():181-90. PubMed ID: 6446876
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 38. A hypothesis--Peptide library generated by cathepsin S might be efficacious for allergen-specific immunotherapy.
    Li C; Jiang Y; Li L
    Vaccine; 2010 Feb; 28(5):1135-7. PubMed ID: 19948264
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic responses to sublingual allergen immunotherapy.
    Akdis M
    Clin Allergy Immunol; 2008; 21():71-86. PubMed ID: 18828499
    [No Abstract]   [Full Text] [Related]  

  • 40. Human suppressor cells.
    Panayi GS
    Agents Actions Suppl; 1980; 7():121-5. PubMed ID: 6454332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.